Imexpharm Corp (IMP) — Free Cash Flow Generation Index
Imexpharm Corp (IMP) has a Free Cash Flow Generation Index of 0.92x as of March 2026. Free cash flow of ₫95.71 Billion represents 1% of operating cash flow (₫103.49 Billion). See Imexpharm Corp short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Imexpharm Corp Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Imexpharm Corp across 6 annual periods. Explore Imexpharm Corp debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Imexpharm Corp (2019–2025)
Year-by-year Free Cash Flow Generation Index for Imexpharm Corp. For the full company profile including market capitalisation, see IMP company net worth.
| Year | FCG Index | Free Cash Flow (VND) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | ₫27.29 Billion | ₫54.17 Billion | ₫26.88 Billion | ▼ -8.8% |
| 2024 | 0.55x | ₫119.50 Billion | ₫216.27 Billion | ₫96.77 Billion | ▼ -25.1% |
| 2022 | 0.74x | ₫279.25 Billion | ₫378.60 Billion | ₫99.35 Billion | ▼ -4.8% |
| 2021 | 0.77x | ₫182.02 Billion | ₫234.88 Billion | ₫52.86 Billion | ▲ +442.9% |
| 2020 | -0.23x | ₫-16.53 Billion | ₫73.15 Billion | ₫89.68 Billion | ▲ +76.7% |
| 2019 | -0.97x | ₫-64.53 Billion | ₫66.59 Billion | ₫131.12 Billion | — |